Home Newsfeeds Keybanc Downgrades Exelon to Sector Weight

Keybanc Downgrades Exelon to Sector Weight

Keybanc analyst Sophie Karp downgrades Exelon (NASDAQ:EXC) from Overweight to Sector Weight.

byBenzinga Newsdesk

October 20, 2022

1 minute read

Keybanc analyst Sophie Karp downgrades Exelon (NASDAQ:EXC) from Overweight to Sector Weight.

Reported Earlier, ‘Biden-Harris Administration Announced It Expects To Invest Over $5B In Semiconductor-Related Research, Development, And Workforce Needs, Including In The NSTC, To Advance President Biden’s Goals Of Driving R&D In The U.S.’

By Benzinga Newsdesk

February 9, 4:13 PM

https://www.whitehouse.gov/briefing-room/statements-releases/2024/02/09/fact-sheet-biden-harris-administration-announces-over-5-billion-from-the-chips-and-science-act-for-research-development-and-workforce/The

AMD

Dogecoin In Danger Zone? Analyst Predicts Potential Decline Amid Perplexing Weekly Chart Patterns

By Mehab Qureshi

October 31, 8:14 AM

A pseudonymous crypto analyst, Rekt Capital, has observed a complicated weekly close for Dogecoin (CRYPTO: DOGE), stating that the breakout has been postponed as the 1-week close occurred below the Channel Top resistance.

$DOGE

Aptar Pharma Pays Pharmaxis $5M to Acquire Orbital Technology

By Charles Gross

August 4, 4:52 AM

Clinical stage drug developer Pharmaxis (ASX: PXS) today announced that Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, has exercised the option to acquire the worldwide rights to Pharmaxis' proprietary inhaler Orbital, a unique device designed to deliver high payload dry powder to the lungs.

ATR

How Milady Memecoin Made Its Whales Rich: Top 10 Hodlers Raked In Profits Of Over $26M